DDC
MEDP icon

DF Dent & Co’s Medpace MEDP Stock Holding History

DF Dent & Co’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.1M Buy
96,455
+21,645
+29% +$9.99M 0.97% 31
2026
Q1 		$35.9M Buy
74,810
+20,149
+37% +$10.3M 0.69% 45
2025
Q4 		$30.7M Sell
54,661
-9,469
-15% -$5.38M 0.44% 63
2025
Q3 		$33M Sell
64,130
-89,648
-58% -$39.1M 0.43% 62
2025
Q2 		$48.3M Buy
153,778
+4,320
+3% +$1.3M 0.61% 45
2025
Q1 		$45.5M Buy
149,458
+2,311
+2% +$777K 0.61% 48
2024
Q4 		$48.9M Sell
147,147
-14,151
-9% -$4.8M 0.62% 44
2024
Q3 		$53.8M Buy
161,298
+105,659
+190% +$40.1M 0.65% 44
2024
Q2 		$22.9M Sell
55,639
-2,048
-4% -$811K 0.3% 60
2024
Q1 		$23.3M Sell
57,687
-557
-1% -$196K 0.28% 63
2023
Q4 		$17.9M Buy
58,244
+277
+0.5% +$74.8K 0.24% 64
2023
Q3 		$14M Sell
57,967
-702
-1% -$180K 0.21% 69
2023
Q2 		$14.1M Sell
58,669
-33,501
-36% -$6.96M 0.19% 72
2023
Q1 		$17.3M Buy
92,170
+6,134
+7% +$1.27M 0.24% 58
2022
Q4 		$18.3M Sell
86,036
-14,791
-15% -$2.96M 0.27% 57
2022
Q3 		$15.8M Buy
100,827
+7,868
+8% +$1.26M 0.24% 59
2022
Q2 		$13.9M Sell
92,959
-11,915
-11% -$1.72M 0.2% 66
2022
Q1 		$17.2M Buy
104,874
+3,110
+3% +$513K 0.2% 66
2021
Q4 		$22.1M Buy
101,764
+1,003
+1% +$210K 0.22% 60
2021
Q3 		$19.1M Buy
100,761
+5,599
+6% +$1.02M 0.2% 59
2021
Q2 		$16.8M Buy
95,162
+16,075
+20% +$2.77M 0.18% 67
2021
Q1 		$13M Buy
+79,087
New +$12.1M 0.15% 71

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DF Dent & Co's MEDP Position: Q2 2026 in Review

DF Dent & Co increased its Medpace (MEDP) stake by 29% in Q2 2026, buying an estimated $9.99M and bringing the position to 96,455 shares worth $51.1M. The position accounts for 0.97% of the portfolio, ranked #31.

DF Dent & Co first reported a position in MEDP in Q1 2021 and has held it in 22 quarters since. The position peaked at $53.8M in Q3 2024. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • DF Dent & Co held 96,455 shares of Medpace worth $51.1M as of Q2 2026.
  • DF Dent & Co bought 21,645 Medpace shares in Q2 2026, an estimated $9.99M.
  • Medpace made up 0.97% of DF Dent & Co's portfolio in Q2 2026, its #31 holding.
  • DF Dent & Co first reported a position in Medpace in Q1 2021 and has held it in 22 quarters since.
  • DF Dent & Co's Medpace position peaked at $53.8M in Q3 2024.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on DF Dent & Co's 13F filing for Q2 2026, filed 14 Aug 2026.